PolyHEMA Sensor Membranes for Dexamethasone Rejection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Amperometric glucose sensors used in diabetes management are adversely affected by dexamethasone acetate, leading to decreased signal integrity and accuracy.
Innovation Solution
A dexamethasone rejection membrane (DRM) composed of poly(2-hydroxyethyl methacrylate) compositions is integrated into the sensor design to prevent dexamethasone penetration while maintaining glucose diffusivity, thereby enhancing sensor accuracy and reducing interference from other substances like acetaminophen.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If dexamethasone acetate is used to extend sensor in vivo life-time, then sensor durability is improved, but sensor signal accuracy deteriorates due to interference with amperometric readings
Solution Approach 1:
The sensor membrane is segmented into multiple functional layers: a dexamethasone rejection membrane layer that blocks DXAC penetration while allowing glucose diffusion, and an outer glucose limiting membrane layer. This segmentation allows the sensor to simultaneously achieve extended durability through DXAC rejection and maintained accuracy through selective glucose permeability.
Solution Approach 2:
The dexamethasone rejection membrane acts as an intermediary barrier between the sensing element and the external environment. It selectively intercepts dexamethasone acetate molecules, preventing them from reaching and interfering with the amperometric sensing elements, while permitting glucose to pass through to the sensing layer.
2Measurement precision
If a rejection membrane is added to block dexamethasone, then sensor accuracy is improved, but device complexity increases
Solution Approach 1:
The dexamethasone rejection functionality is merged with the existing membrane structure by incorporating it as an additional layer in the membrane assembly. This integration approach maintains the simplicity of the overall device while adding the necessary rejection capability, avoiding the need for separate complex rejection mechanisms.
Solution Approach 2:
The rejection membrane layer serves multiple functions: it blocks dexamethasone acetate penetration, maintains glucose diffusion pathways, and preserves oxygen transport. This multi-functionality reduces the need for additional separate components, thereby limiting the increase in device complexity while achieving improved accuracy.
3Measurement precision
If membrane thickness is increased to improve dexamethasone rejection, then rejection effectiveness is improved, but glucose diffusivity deteriorates
Solution Approach 1:
The membrane exhibits local quality variations at the molecular level: it has high rejection properties for dexamethasone acetate molecules while maintaining high permeability for glucose molecules. This is achieved through selective polymer composition and pore structure that are locally optimized to differentiate between DXAC and glucose based on their molecular characteristics.
Solution Approach 2:
The membrane parameters are optimized to achieve the desired balance: thickness is controlled at a specific range (e.g., 1-10 micrometers) to provide sufficient rejection path length for DXAC while maintaining adequate glucose flux. The polymer composition and crosslinking density are adjusted to create pore sizes that selectively exclude DXAC molecules while permitting glucose passage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The DRM effectively prevents dexamethasone interference, improving sensor signal stability and accuracy, and reducing the impact of other interferents, thus maintaining reliable glucose readings.
Implementation Method 1
a dexamethasone rejection membrane (DRM), made from materials selected to prevent dexamethasone from penetrating into sensing elements of amperometric sensors
Implementation Method 2
the DRM layer can further reduce the impact of acetaminophen (AC) and other interferents on the glucose sensor signal
Data Source
AI summary
Embodiments of the invention provide amperometric analyte sensors having optimized elements such as dexamethasone rejection membranes as well as methods for making and using such sensors. The amperometric analyte sensor apparatus comprises: a base layer; a conductive layer disposed on the base layer and comprising a working electrode; an dexamethasone rejection membrane disposed over an electroactive surface of the working electrode, wherein the interference rejection membrane comprises a poly Hema composition and an analyte sensing layer. While embodiments of the innovation can be used in a variety of contexts, typical embodiments of the invention include glucose sensors used in the management of diabetes.